221 related articles for article (PubMed ID: 38489287)
1. The impact of metabolic syndrome severity on racial and ethnic disparities in Metabolic Dysfunction-Associated Steatotic Liver Disease.
Elsaid MI; Bridges JFP; Mumtaz K; Li N; Sobotka L; Rustgi VK; Paskett ED
PLoS One; 2024; 19(3):e0299836. PubMed ID: 38489287
[TBL] [Abstract][Full Text] [Related]
2. An examination of sex and racial/ethnic differences in the metabolic syndrome among adults: a confirmatory factor analysis and a resulting continuous severity score.
Gurka MJ; Lilly CL; Oliver MN; DeBoer MD
Metabolism; 2014 Feb; 63(2):218-25. PubMed ID: 24290837
[TBL] [Abstract][Full Text] [Related]
3. Racial and ethnic differences and the role of unfavorable social determinants of health across steatotic liver disease subtypes in the United States.
Ochoa-Allemant P; Marrero JA; Serper M
Hepatol Commun; 2023 Dec; 7(12):. PubMed ID: 38051551
[TBL] [Abstract][Full Text] [Related]
4. Racial/ethnic discrepancies in the metabolic syndrome begin in childhood and persist after adjustment for environmental factors.
Walker SE; Gurka MJ; Oliver MN; Johns DW; DeBoer MD
Nutr Metab Cardiovasc Dis; 2012 Feb; 22(2):141-8. PubMed ID: 20708390
[TBL] [Abstract][Full Text] [Related]
5. Racial/ethnic and sex differences in the relationship between uric acid and metabolic syndrome in adolescents: an analysis of National Health and Nutrition Survey 1999-2006.
DeBoer MD; Dong L; Gurka MJ
Metabolism; 2012 Apr; 61(4):554-61. PubMed ID: 22000606
[TBL] [Abstract][Full Text] [Related]
6. Racial disparities in evidence-based management of metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes.
Alexopoulos AS; Parish A; Olsen M; Batch BC; Moylan CA; Crowley MJ
Endocr Pract; 2024 Apr; ():. PubMed ID: 38697305
[TBL] [Abstract][Full Text] [Related]
7. Greater healthful food variety as measured by the US Healthy Food Diversity index is associated with lower odds of metabolic syndrome and its components in US adults.
Vadiveloo M; Parekh N; Mattei J
J Nutr; 2015 Mar; 145(3):564-71. PubMed ID: 25733473
[TBL] [Abstract][Full Text] [Related]
8. Dietary macro and micronutrients associated with MASLD: Analysis of a national US cohort database.
Nemer M; Osman F; Said A
Ann Hepatol; 2024; 29(3):101491. PubMed ID: 38412922
[TBL] [Abstract][Full Text] [Related]
9. Low sensitivity for the metabolic syndrome to detect uric acid elevations in females and non-Hispanic-black male adolescents: an analysis of NHANES 1999-2006.
DeBoer MD; Gurka MJ
Atherosclerosis; 2012 Feb; 220(2):575-80. PubMed ID: 22178428
[TBL] [Abstract][Full Text] [Related]
10. Prevalence, trends, and characteristics of metabolic dysfunction-associated steatotic liver disease among the US population aged 12-79 years.
Shen TH; Wu CH; Lee YW; Chang CC
Eur J Gastroenterol Hepatol; 2024 May; 36(5):636-645. PubMed ID: 38477858
[TBL] [Abstract][Full Text] [Related]
11. Females, Hispanics and older individuals are at greatest risk of developing metabolic syndrome in the U.S.
Campbell B; Aguilar M; Bhuket T; Torres S; Liu B; Wong RJ
Diabetes Metab Syndr; 2016; 10(4):230-233. PubMed ID: 27342003
[TBL] [Abstract][Full Text] [Related]
12. Metabolic syndrome and impaired health-related quality of life and in non-Hispanic White, non-Hispanic Blacks and Mexican-American Adults.
Okosun IS; Annor F; Esuneh F; Okoegwale EE
Diabetes Metab Syndr; 2013; 7(3):154-60. PubMed ID: 23953181
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and predictors of obesity-related cancers among racial/ethnic groups with metabolic syndrome.
Monestime S; Beech B; Kermah D; Norris K
PLoS One; 2021; 16(4):e0249188. PubMed ID: 33826671
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D status and prevalence of metabolic syndrome by race and Hispanic origin in US adults: findings from the 2007-2014 NHANES.
Ahluwalia N; Raghavan R; Zhang G; Talegawkar SA; Jacques PF
Am J Clin Nutr; 2022 Nov; 116(5):1400-1408. PubMed ID: 36036472
[TBL] [Abstract][Full Text] [Related]
15. Trends in Oxidative Balance Score and Prevalence of Metabolic Dysfunction-Associated Steatotic Liver Disease in the United States: National Health and Nutrition Examination Survey 2001 to 2018.
Tan Z; Wu Y; Meng Y; Liu C; Deng B; Zhen J; Dong W
Nutrients; 2023 Nov; 15(23):. PubMed ID: 38068789
[TBL] [Abstract][Full Text] [Related]
16. The severity of the metabolic syndrome increases over time within individuals, independent of baseline metabolic syndrome status and medication use: The Atherosclerosis Risk in Communities Study.
Vishnu A; Gurka MJ; DeBoer MD
Atherosclerosis; 2015 Nov; 243(1):278-85. PubMed ID: 26409627
[TBL] [Abstract][Full Text] [Related]
17. Geographical variation in the prevalence of obesity, metabolic syndrome, and diabetes among US adults.
Gurka MJ; Filipp SL; DeBoer MD
Nutr Diabetes; 2018 Mar; 8(1):14. PubMed ID: 29549249
[TBL] [Abstract][Full Text] [Related]
18. A Study of Dietary Patterns Derived by Cluster Analysis and Their Association With Metabolic Dysfunction-Associated Steatotic Liver Disease Severity Among Hispanic Patients.
Zhang X; Daniel CR; Soltero V; Vargas X; Jain S; Kanwal F; Thrift AP; Balakrishnan M
Am J Gastroenterol; 2023 Oct; ():. PubMed ID: 37737674
[TBL] [Abstract][Full Text] [Related]
19. Trends in Racial/Ethnic Disparities in Cardiovascular Health Among US Adults From 1999-2012.
Pool LR; Ning H; Lloyd-Jones DM; Allen NB
J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28939713
[TBL] [Abstract][Full Text] [Related]
20. Serum Alanine Aminotransferase Trends and Their Relationship with Obesity and Metabolic Syndrome in United States Adolescents, 1999-2014.
Fermin CR; Lee AM; Filipp SL; Gurka MJ; DeBoer MD
Metab Syndr Relat Disord; 2017 Aug; 15(6):276-282. PubMed ID: 28520503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]